{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:16:48Z","timestamp":1790324208049,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T00:00:00Z","timestamp":1306800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020547","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T21:23:34Z","timestamp":1306877014000},"page":"e20547","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Vaccination with Plasmodium knowlesi AMA1 Formulated in the Novel Adjuvant Co-Vaccine HT\u2122 Protects against Blood-Stage Challenge in Rhesus Macaques"],"prefix":"10.1371","volume":"6","author":[{"given":"Muzamil","family":"Mahdi Abdel Hamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond J.","family":"Remarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie M.","family":"van Duivenvoorde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"van der Werff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Walraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart W.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens H. M.","family":"Kocken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e1000290","DOI":"10.1371\/journal.pmed.1000290","article-title":"Estimating the global clinical burden of <italic>Plasmodium falciparum<\/italic> Malaria in 2007.","volume":"7","author":"SI Hay","year":"2010","journal-title":"PLoS Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/600121","article-title":"A malaria vaccine for control: more progress.","volume":"200","author":"JG Breman","year":"2009","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03342","article-title":"The global distribution of clinical episodes of <italic>Plasmodium falciparum<\/italic> malaria.","volume":"434","author":"RW Snow","year":"2005","journal-title":"Nature"},{"key":"ref4","first-page":"297","article-title":"Rat monoclonal antibodies which inhibit the in vitro multiplication of <italic>Plasmodium knowlesi<\/italic>.","volume":"49","author":"JA Deans","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0166-6851(84)90065-3","article-title":"Biosynthesis of a putative protective <italic>Plasmodium knowlesi<\/italic> merozoite antigen.","volume":"11","author":"JA Deans","year":"1984","journal-title":"Mol Biochem Parasitol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-3024.1988.tb00241.x","article-title":"Vaccination trials in rhesus monkeys with a minor, invariant, <italic>Plasmodium knowlesi<\/italic> 66 kD merozoite antigen.","volume":"10","author":"JA Deans","year":"1988","journal-title":"Parasite Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pt.2007.12.002","article-title":"Apical membrane antigen 1: a malaria vaccine candidate in review.","volume":"24","author":"EJ Remarque","year":"2008","journal-title":"Trends Parasitol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e8138","DOI":"10.1371\/journal.pone.0008138","article-title":"High antibody titer against apical membrane antigen-1 is required to protect against malaria in the <italic>Aotus<\/italic> model.","volume":"4","author":"S Dutta","year":"2009","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4269\/ajtmh.1994.51.711","article-title":"Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of <italic>Plasmodium fragile<\/italic>.","volume":"51","author":"WE Collins","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref10","article-title":"The Primate Malarias.","author":"GR Coatney","year":"1971","journal-title":"U.S. Department of Health, Education and Welfare"},{"key":"ref11","first-page":"503","article-title":"Antigenic variation and protective immunity in <italic>Plasmodium knowlesi<\/italic> malaria.","volume":"23","author":"GA Butcher","year":"1972","journal-title":"Immunology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trstmh.2009.05.017","article-title":"<italic>Plasmodium knowlesi<\/italic> infections in a small number of non-immune natural hosts (<italic>Macaca fascicularis<\/italic>) and in rhesus monkeys (<italic>M. mulatta<\/italic>).","volume":"104","author":"GA Butcher","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/524888","article-title":"<italic>Plasmodium knowlesi<\/italic> malaria in humans is widely distributed and potentially life threatening.","volume":"46","author":"J Cox-Singh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(04)15836-4","article-title":"A large focus of naturally acquired <italic>Plasmodium knowlesi<\/italic> infections in human beings.","volume":"363","author":"B Singh","year":"2004","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for <italic>Plasmodium falciparum<\/italic> malaria.","volume":"73","author":"EM Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e3960","DOI":"10.1371\/journal.pone.0003960","article-title":"Safety and immunogenicity of a recombinant <italic>Plasmodium falciparum<\/italic> AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.","volume":"3","author":"M Roestenberg","year":"2008","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e2940","DOI":"10.1371\/journal.pone.0002940","article-title":"Phase 1 trial of AMA1-C1\/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for <italic>Plasmodium falciparum<\/italic> malaria.","volume":"3","author":"GE Mullen","year":"2008","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.vaccine.2009.12.049","article-title":"Phase 1 safety and immunogenicity trial of the <italic>Plasmodium falciparum<\/italic> blood-stage malaria vaccine AMA1-C1\/ISA 720 in Australian adults.","volume":"28","author":"MA Pierce","year":"2010","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.vaccine.2004.09.040","article-title":"A human phase 1 vaccine clinical trial of the <italic>Plasmodium falciparum<\/italic> malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant.","volume":"23","author":"A Saul","year":"2005","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e5254","DOI":"10.1371\/journal.pone.0005254","article-title":"Phase 1\/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.","volume":"4","author":"MD Spring","year":"2009","journal-title":"PLoS One"},{"key":"ref21","article-title":"Extended safety, immunogenicity and efficacy of Water Reed Army Institute of Research&apos;s AMA-1 malaria vaccine (FMP2.1) adjuvanted in GSK Biological&apos;s AS02A in 1\u20136 year old children in Bandiagara, Mali.","author":"MA Thera","year":"2010","journal-title":"American Society of Tropical Medicine and Hygiene 59"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2009.03.014","article-title":"A randomized controlled phase 2 trial of the blood stage AMA1-C1\/Alhydrogel malaria vaccine in children in Mali.","volume":"27","author":"I Sagara","year":"2009","journal-title":"Vaccine"},{"key":"ref23","article-title":"Allele-specificity of the monovalent Apical Membrane Antigen 1 (AMA1) malaria vaccine FMP2.1\/AS02A.","author":"A Ouattara","year":"2010","journal-title":"American Society of Tropical Medicine and Hygiene 59"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0169-4758(96)10062-4","article-title":"Models for malaria: Nature knows best.","volume":"12","author":"GA Butcher","year":"1996","journal-title":"Parasitol Today"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1016\/j.vaccine.2008.08.055","article-title":"Production, quality control, stability and pharmacotoxicity of cGMP-produced <italic>Plasmodium falciparum<\/italic> AMA1 FVO strain ectodomain expressed in Pichia pastoris.","volume":"26","author":"BW Faber","year":"2008","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.vaccine.2004.07.021","article-title":"Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition.","volume":"23","author":"AG Blom","year":"2004","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.4049\/jimmunol.1001760","article-title":"Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.","volume":"185","author":"SJ Draper","year":"2010","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.vaccine.2005.01.133","article-title":"Sucrose fatty acid sulphate esters as novel vaccine adjuvant.","volume":"24","author":"LA Hilgers","year":"2006","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/IAI.70.8.4471-4476.2002","article-title":"High-level expression of the malaria blood-stage vaccine candidate <italic>Plasmodium falciparum<\/italic> apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.","volume":"70","author":"CH Kocken","year":"2002","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes.","volume":"82","author":"JH Draize","year":"1944","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture.","volume":"193","author":"W Trager","year":"1976","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1128\/IAI.70.12.6948-6960.2002","article-title":"In vitro studies with recombinant <italic>Plasmodium falciparum<\/italic> apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.","volume":"70","author":"MC Kennedy","year":"2002","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0264-410X(97)88331-4","article-title":"Immunisation with recombinant AMA-1 protects mice against infection with <italic>Plasmodium chabaudi<\/italic>.","volume":"16","author":"RF Anders","year":"1998","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/IAI.72.8.4464-4470.2004","article-title":"Production of the subdomains of the <italic>Plasmodium falciparum<\/italic> apical membrane antigen 1 ectodomain and analysis of the immune response.","volume":"72","author":"PV Lalitha","year":"2004","journal-title":"Infect Immun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria.","volume":"192","author":"S Cohen","year":"1961","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-3156.1996.d01-89.x","article-title":"<italic>Plasmodium falciparum<\/italic> malaria in the first year of life in an area of intense and perennial transmission.","volume":"1","author":"AY Kitua","year":"1996","journal-title":"Trop Med Int Health"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2249.1997.tb08319.x","article-title":"Isotypic analysis of maternally transmitted <italic>Plasmodium falciparum<\/italic>-specific antibodies in Cameroon, and relationship with risk of <italic>P. falciparum<\/italic> infection.","volume":"110","author":"P Deloron","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.165.1.389","article-title":"CD4+ T cells acting independently of antibody contribute to protective immunity to <italic>Plasmodium chabaudi<\/italic> infection after apical membrane antigen 1 immunization.","volume":"165","author":"H Xu","year":"2000","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1371\/journal.pone.0001063","article-title":"Protection of rhesus monkeys by a DNA prime\/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.","volume":"2","author":"WR Weiss","year":"2007","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e6559","DOI":"10.1371\/journal.pone.0006559","article-title":"Sterile protection against <italic>Plasmodium knowlesi<\/italic> in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.","volume":"4","author":"G Jiang","year":"2009","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-29","article-title":"Malaria infection by sporozoite challenge induces high functional antibody titres against blood stage antigens after a DNA prime, poxvirus boost vaccination strategy in Rhesus macaques.","volume":"10","author":"M Mahdi Abdel Hamid","year":"2011","journal-title":"Malar J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.micinf.2007.07.009","article-title":"Extended immunization intervals enhance the immunogenicity and protective efficacy of plasmid DNA vaccines.","volume":"9","author":"GT Brice","year":"2007","journal-title":"Microbes Infect"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nm.1850","article-title":"Effective induction of high-titer antibodies by viral vector vaccines.","volume":"14","author":"SJ Draper","year":"2008","journal-title":"Nat Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e10685","DOI":"10.1371\/journal.pone.0010685","article-title":"Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.","volume":"5","author":"DL Guilbride","year":"2010","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T22:35:41Z","timestamp":1741214141000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020547"}},"subtitle":[],"editor":[{"given":"Denise L.","family":"Doolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020547","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}